Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Modulating Pathogenesis with Mobile-CRISPRi.

Qu J, Prasad NK, Yu MA, Chen S, Lyden A, Herrera N, Silvis MR, Crawford E, Looney MR, Peters JM, Rosenberg OS.

J Bacteriol. 2019 Oct 21;201(22). pii: e00304-19. doi: 10.1128/JB.00304-19. Print 2019 Nov 15.

PMID:
31481541
2.

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.

Kundert K, Lucas JE, Watters KE, Fellmann C, Ng AH, Heineike BM, Fitzsimmons CM, Oakes BL, Qu J, Prasad N, Rosenberg OS, Savage DF, El-Samad H, Doudna JA, Kortemme T.

Nat Commun. 2019 May 9;10(1):2127. doi: 10.1038/s41467-019-09985-2.

3.

Enabling genetic analysis of diverse bacteria with Mobile-CRISPRi.

Peters JM, Koo BM, Patino R, Heussler GE, Hearne CC, Qu J, Inclan YF, Hawkins JS, Lu CHS, Silvis MR, Harden MM, Osadnik H, Peters JE, Engel JN, Dutton RJ, Grossman AD, Gross CA, Rosenberg OS.

Nat Microbiol. 2019 Feb;4(2):244-250. doi: 10.1038/s41564-018-0327-z. Epub 2019 Jan 7.

4.

Imaging Active Infection in vivo Using D-Amino Acid Derived PET Radiotracers.

Neumann KD, Villanueva-Meyer JE, Mutch CA, Flavell RR, Blecha JE, Kwak T, Sriram R, VanBrocklin HF, Rosenberg OS, Ohliger MA, Wilson DM.

Sci Rep. 2017 Aug 11;7(1):7903. doi: 10.1038/s41598-017-08415-x.

5.

Chlamydia interfere with an interaction between the mannose-6-phosphate receptor and sorting nexins to counteract host restriction.

Elwell CA, Czudnochowski N, von Dollen J, Johnson JR, Nakagawa R, Mirrashidi K, Krogan NJ, Engel JN, Rosenberg OS.

Elife. 2017 Mar 2;6. pii: e22709. doi: 10.7554/eLife.22709.

6.

Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion.

Rosenberg OS, Dovala D, Li X, Connolly L, Bendebury A, Finer-Moore J, Holton J, Cheng Y, Stroud RM, Cox JS.

Cell. 2015 Apr 23;161(3):501-512. doi: 10.1016/j.cell.2015.03.040. Epub 2015 Apr 9.

7.

Structure of a new DNA-binding domain which regulates pathogenesis in a wide variety of fungi.

Lohse MB, Rosenberg OS, Cox JS, Stroud RM, Finer-Moore JS, Johnson AD.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10404-10. doi: 10.1073/pnas.1410110111. Epub 2014 Jul 3.

8.

The crystal structure of S. cerevisiae Sad1, a catalytically inactive deubiquitinase that is broadly required for pre-mRNA splicing.

Hadjivassiliou H, Rosenberg OS, Guthrie C.

RNA. 2014 May;20(5):656-69. doi: 10.1261/rna.042838.113. Epub 2014 Mar 28.

9.

Immune reconstitution reactions in human immunodeficiency virus-negative patients: report of a case and review of the literature.

Scharschmidt TC, Amerson EH, Rosenberg OS, Jacobs RA, McCalmont TH, Shinkai K.

JAMA Dermatol. 2013 Jan;149(1):74-8. doi: 10.1001/2013.jamadermatol.503. Review.

10.

A mechanism for tunable autoinhibition in the structure of a human Ca2+/calmodulin- dependent kinase II holoenzyme.

Chao LH, Stratton MM, Lee IH, Rosenberg OS, Levitz J, Mandell DJ, Kortemme T, Groves JT, Schulman H, Kuriyan J.

Cell. 2011 Sep 2;146(5):732-45. doi: 10.1016/j.cell.2011.07.038. Erratum in: Cell. 2011 Oct 28;147(3):704.

11.

EspR, a key regulator of Mycobacterium tuberculosis virulence, adopts a unique dimeric structure among helix-turn-helix proteins.

Rosenberg OS, Dovey C, Tempesta M, Robbins RA, Finer-Moore JS, Stroud RM, Cox JS.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13450-5. doi: 10.1073/pnas.1110242108. Epub 2011 Jul 27.

12.

Oligomerization states of the association domain and the holoenyzme of Ca2+/CaM kinase II.

Rosenberg OS, Deindl S, Comolli LR, Hoelz A, Downing KH, Nairn AC, Kuriyan J.

FEBS J. 2006 Feb;273(4):682-94.

13.

Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme.

Rosenberg OS, Deindl S, Sung RJ, Nairn AC, Kuriyan J.

Cell. 2005 Dec 2;123(5):849-60.

14.

Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing.

Terlouw DJ, Nahlen BL, Courval JM, Kariuki SK, Rosenberg OS, Oloo AJ, Kolczak MS, Hawley WA, Lal AA, Kuile FO.

Antimicrob Agents Chemother. 2003 Sep;47(9):2929-32.

15.

Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya.

Terlouw DJ, Courval JM, Kolczak MS, Rosenberg OS, Oloo AJ, Kager PA, Lal AA, Nahlen BL, ter Kuile FO.

J Infect Dis. 2003 Feb 1;187(3):467-76. Epub 2003 Jan 24.

PMID:
12552431

Supplemental Content

Loading ...
Support Center